The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Picking the right small caps isn’t easy, and that’s exactly why StockStory exists - to help you focus on the best opportunities. Keeping that in mind, here is one Russell 2000 stock that could be a breakout winner and two that may struggle to keep up.
Two Stocks to Sell:
Onterris (ONT)
Market Cap: $617.4 million
Founded to protect a tree-lined two-lane road, Onterris (NYSE: ONT) provides air quality monitoring, environmental laboratory testing, compliance, and environmental consulting services.
Why Does ONT Worry Us?
- Sales are projected to remain flat over the next 12 months as demand decelerates from its two-year trend
- Poor expense management has led to operating margin losses
- Push for growth has led to negative returns on capital, signaling value destruction
Onterris’s stock price of $17.58 implies a valuation ratio of 12.1x forward P/E. Dive into our free research report to see why there are better opportunities than ONT.
Genco (GNK)
Market Cap: $1.19 billion
Headquartered in NYC, Genco (NYSE: GNK) is a shipping company that transports dry bulk cargo along worldwide maritime routes.
Why Do We Avoid GNK?
- Number of owned vessels has disappointed over the past two years, indicating weak demand for its offerings
- Performance over the past two years shows its incremental sales were less profitable as its earnings per share were flat
- Free cash flow margin dropped by 81.8 percentage points over the last five years, implying the company became more capital intensive as competition picked up
Genco is trading at $27.28 per share, or 11.7x forward P/E. To fully understand why you should be careful with GNK, check out our full research report (it’s free).
One Stock to Watch:
iRhythm (IRTC)
Market Cap: $4.07 billion
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ: IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services that help physicians detect and diagnose heart rhythm disorders.
Why Is IRTC on Our Radar?
- Annual revenue growth of 24% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 17.4% annually over the last five years and trumped its peers
- Free cash flow turned positive over the last five years, showing the company is at an important crossroads
At $123.39 per share, iRhythm trades at 186.9x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
